Navigation Links
Cedars-Sinai study: How does a 'good' protein hurt brain cells after clot-induced stroke?

LOS ANGELES -- The National Institutes of Health has awarded a four-year, $1.4 million grant to Cedars-Sinai's Department of Neurology to study an unexpected recent discovery: After ischemic stroke the type caused by a clogged artery but with no bleeding into the brain a normal protein that plays a positive role in blood clotting escapes intact arteries and damages healthy brain cells.

"We knew thrombin leaked out during hemorrhagic strokes those in which an artery ruptures and we knew that in large amounts it killed brain cells. But we decided to see if there was thrombin after ischemic stroke, and, surprisingly, there was a lot, and it was causing major damage to brain cells. When we injected a drug that counters the effects of thrombin, stroke symptoms got better," said Patrick D. Lyden, MD, chair of the Department of Neurology and the Carmen and Louis Warschaw Chair in Neurology at Cedars-Sinai.

He was senior author of a 2010 article in the journal Stroke that described this phenomenon and suggested possible underlying mechanisms. The new grant, he said, will let researchers delve more deeply: Where is the thrombin coming from? What kinds of cells does it kill? What factors inhibit or enhance its effects?

Lyden will continue his work with Roger Y. Tsien, a scientist at the University of California, San Diego. He is one of three winners of the 2008 Nobel Prize in chemistry for development of green fluorescent protein.

Lyden's study will use fluorescence in rats and mice to light up thrombin and follow its migration and interactions with other molecules in blood vessels and brain tissue.

This is the first NIH funding directly awarded to the Department of Neurology, evidence of its growth since Lyden's arrival in 2009. He and other researchers are also supported by other NIH grants received before he joined Cedars-Sinai.

Contact: Sandy Van
Cedars-Sinai Medical Center

Page: 1

Related medicine news :

1. TGen and Virginia G. Piper Cancer Center form drug development collaboration with Cedars-Sinai
2. Cedars-Sinai scientists, physicians to be key presenters at World Stem Cell Summit
3. Cedars-Sinai movement disorders expert on international task force for dystonia treatment
4. Latest data from Cedars-Sinai vaccine study supports immune targeting of brain tumors
5. Cedars-Sinais mobile medical clinics receive $500,000 grant from California Community Foundation
6. Cedars-Sinai to hold first annual conference on stem cell therapies for neurological disorders
7. Cedars-Sinais mobile medical clinics receive grant from George Hoag Family Foundation
8. Cedars-Sinai research team awarded $1.9 million from CIRM to develop new tools and technologies
9. Cedars-Sinai Medical Genetics Institute director honored with lifetime achievement award
10. Cedars-Sinai nano-drug hits brain-tumor target found in 2001
11. Cedars-Sinai awarded $1.9 million from CIRM to develop stem cell treatments for osteoporosis
Post Your Comments:
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda Cheng, an ... Cheng has extensive experience with all areas of orthodontics, including robotic Suresmile technology, ... , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. It can be ...
(Date:6/24/2016)... ... ... makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for a Fair Minimum ... by 2020 and then adjusting it yearly to increase at the same rate as the ... wage floor does not erode again, and make future increases more predictable. , The company ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Clinical Decision Making in Emergency Medicine conference in Ponte Vedra Beach, FL. The ... published in Emergency Medicine Practice and Pediatric Emergency Medicine Practice. , ...
(Date:6/24/2016)... ... June 24, 2016 , ... Puradigm® & Innovative ... has initiated cultivation and processing operations at its production facility, and opened its ... Puradigm is the manufacturer of a complete system of proactive air and surface ...
(Date:6/24/2016)... ... June 24, 2016 , ... National recruitment firm Slone Partners ... extensive sequencing and genomics experience, as Vice President of North American Capital Sales at ... responsible for leading the sales team in the commercialization of the HTG EdgeSeq system ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 23, 2016 Capricor Therapeutics, ... a biotechnology company focused on the discovery, development ... patient enrollment in its ongoing randomized HOPE-Duchenne clinical ... 50% of its 24-patient target. Capricor expects the ... quarter of 2016, and to report top line ...
(Date:6/23/2016)... Calif. , June 23, 2016 ... CST on Thursday, July 7, 2016 , , , , ... ) , , , , EXPERT PANELISTS:  , , ... Naik; Senior Industry Analyst, Christi Bird; Senior Industry Analyst, Divyaa Ravishankar ... The global pharmaceutical industry is witnessing an exceptional ...
(Date:6/23/2016)... 23, 2016 Revolutionary technology includes ... Oticon , industry leaders in advanced audiology and hearing ... Oticon Opn ™, the world,s first internet connected hearing ... IoT devices.      (Photo: ... number of ,world firsts,: , TwinLink™ - ...
Breaking Medicine Technology: